Companies / Pliant Therapeutics, Inc. / Activity
Activity — Pliant Therapeutics, Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Kuo Minnie Executive | Sell | Common Stock | $8.9K | -7K -15.47% | 37,806 0.06% of shares | low |
| Jan 20, 2026 | Cheung Lily Executive | Sell | Common Stock | $9.6K | -8K -14.38% | 44,847 0.07% of shares | low |
| Jan 20, 2026 | Cummings Keith Lamont Executive | Sell | Common Stock | $30.7K | -24K -7.47% | 297,214 0.48% of shares | low |
| Jan 20, 2026 | Coulie Bernard CEO | Sell | Common Stock | $114.4K | -89K -15.02% | 505,601 0.82% of shares | medium |
| Jun 11, 2026 | Crowell Gayle a Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.11% of shares | low |
| Jan 22, 2026 | Cummings Keith Lamont Executive | Grant | Stock Option (Right to Buy) | — | +400K | 400,000 0.65% of shares | low |
| Jan 22, 2026 | Coulie Bernard CEO | Grant | Stock Option (Right to Buy) | — | +1.2M | 1,230,000 1.99% of shares | low |
| Jan 22, 2026 | Kuo Minnie Executive | Grant | Stock Option (Right to Buy) | — | +300K | 300,000 0.48% of shares | low |
| Jan 22, 2026 | Cheung Lily Executive | Grant | Stock Option (Right to Buy) | — | +300K | 300,000 0.48% of shares | low |